Generic Name: Insulin Aspart Injection

English Name: Insulin Aspart Injection

Chinese Phonetic Symbols: Mendong Yidaosu Zhusheye

Composition: Chemical Name: Insulin Aspart (manufactured through gene recombination technology by the use of yeasts).

1ml solution contains 100 units (100U) insulin aspart (equivalent to 3.5mg).

Indication: UBLIN is indicated for the treatment of diabetes mellitus.

Strength: 3 ml: 300 units (cartridge).

Dosage and Administration: Individualize and adjust the dosage of UBLIN^® based on patient’s medical conditions. The drug is injected subcutaneously at the abdominal wall, thigh, triceps of upper arm, or the buttocks. This drug can be administered using an insulin pump for continuous subcutaneous infusion. When necessary, administer the drug intravenously by a healthcare professional.

Package: the product is supplied in a glass vial containing 3ml of the product, fitted with a rubber plunger (bromobutyl rubber) and sealed with a rubber pad (bromobutyl rubber).

Shelf life: 18 months

Execution Standard: YBS00652021

Approval No.: National Drug Approval No. S20210027